ARCHIVES

Trial Data: No Benefit In Adding Perifosine to Capecitabine

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

NCI, FDA, Correlogic To Begin Large Trial Of Protein Pattern Diagnostic System for Ovarian Cancer

June 28, 2002

New Colorado Center Gets Core Grant

February 5, 1988

New SEER RFP Sees cheaper Way To Get Data

July 29, 1977

Hamburg Confirmed As FDA Commissioner

May 22, 2009

Clinton Proposes $1.15 Billion Increase For NIH; Support For Cancer Research

January 30, 1998

Genasense Added To Chemo Improves Responses in CLL

December 31, 2004